Apply Now for the 2023 AIM-HI’s Women’s Venture Competition
Applications are now being accepted for the 2023 AIM-HI’s Women’s Venture Competition! Cash prizes will be awarded to the top 3 finalists, and the winning startup will receive up to US$1 million in investment,…
GBM – One of the Most Deadly Cancers
GBM continues to face limited treatment options and devastating survival rates.
AFCR is committed to accelerating breakthrough solutions.
The Urgent Need for Innovation
95%​
GBM kills 95% of patients
within five years of diagnosis​
240,000​
Each Year,…
Advancing Cancer Innovation from Discovery to Patients
For years, the Asian Fund for Cancer Research Limited (AFCR) has believed that scientific discovery alone is not enough. Promising cancer discoveries need support to move beyond the laboratory toward translation, clinical development and ultimately…
Integrating international resources to promote collaboration and accelerate cancer research
